These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 25513716

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
    Nagamoto E, Fujisawa A, Jinnin M, Koga H, Ishii N, Hashimoto T, Yoshino Y.
    J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
    [No Abstract] [Full Text] [Related]

  • 4. Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions.
    Hara H, Makino T, Matsui K, Takegami Y, Koga H, Fukuda S, Ishii N, Hashimoto T, Shimizu T.
    Eur J Dermatol; 2014 Jul; 24(4):488-9. PubMed ID: 25178966
    [No Abstract] [Full Text] [Related]

  • 5. Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid?
    Huang MX, Li ZS, Luo DQ, Lin Q.
    G Ital Dermatol Venereol; 2015 Jun; 150(3):337-9. PubMed ID: 25658439
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ELISA instead of indirect IF in patients with BP: Comment on "Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid".
    Chan LS.
    Arch Dermatol; 2011 Mar; 147(3):291-2. PubMed ID: 21422335
    [No Abstract] [Full Text] [Related]

  • 12. IgG and IgA antibodies in linear IgA/IgG bullous dermatosis target the ectodomain of bullous pemphigoid antigen 2.
    Hertl M, Büdinger L, Christophoridis S, Yancey KB, Borradori L.
    Br J Dermatol; 1999 Apr; 140(4):750-2. PubMed ID: 10233336
    [No Abstract] [Full Text] [Related]

  • 13. [Bullous pemphigoid: diagnosis and therapy].
    Kneisel A, Hertl M.
    Wien Med Wochenschr; 2014 Sep; 164(17-18):363-71. PubMed ID: 25077677
    [Abstract] [Full Text] [Related]

  • 14. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses.
    Feliciani C, Caldarola G, Kneisel A, Podstawa E, Pfütze M, Pfützner W, Hertl M.
    Br J Dermatol; 2009 Aug; 161(2):306-12. PubMed ID: 19485996
    [Abstract] [Full Text] [Related]

  • 15. Blistering insights into the pathogenesis of bullous pemphigoid.
    Wong HK, Bechtel MA.
    Clin Immunol; 2012 Feb; 142(2):101-4. PubMed ID: 22217422
    [No Abstract] [Full Text] [Related]

  • 16. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain.
    Egan CA, Reddy D, Nie Z, Taylor TB, Schmidt LA, Meyer LJ, Petersen MJ, Hashimoto T, Marinkovich MP, Zone JJ.
    J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical and immunological factors associated with bullous pemphigoid relapse.
    Fine JD.
    JAMA Dermatol; 2014 Jan; 150(1):34. PubMed ID: 24226151
    [No Abstract] [Full Text] [Related]

  • 19. Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.
    Zakka LR, Keskin DB, Reche P, Ahmed AR.
    Clin Exp Immunol; 2010 Nov; 162(2):224-36. PubMed ID: 21069937
    [Abstract] [Full Text] [Related]

  • 20. [Bullous pemphigoid].
    Ohyama M, Amagai M.
    Ryoikibetsu Shokogun Shirizu; 2000 Nov; (31):274-6. PubMed ID: 11269078
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.